Nikolaus Krall

EVP Precision Medicine at Excienstia

Speaker

Nikolaus Krall is EVP Precision Medicine at Exscientia, a pioneer in the space of AI enabled drug discovery. In his role, he is responsible for developing, validating and deploying cutting edge technology (translational models, single cell analytics, biomarkers etc.) to put the right drugs into the right patient at the right time with a focus on oncology. Prior to joining Exscientia, he co-founded, built and sold Allcyte, an AI enabled cancer precision medicine company. Originally trained as a chemist he has worked in cancer research and drug discovery for the last 15 years in academia (University of Cambridge, ETH, CeMM) and small and medium biotechs.